Generated: December 12, 2017
DrugPatentWatch Database Preview
Details for Patent: 5,435,076
« Back to Dashboard
Summary for Patent: 5,435,076
|Title:|| Injection device|
|Abstract:||A device for an injection apparatus, including a dual-chamber injection cartridge. The cartridge includes a front end, a rear end, a front opening in the vicinity of a front end of the cartridge, a front chamber located in the vicinity of the front opening and including a drug freeze-dried in the front chamber, a rear chamber including a liquid component, a movable wall separating the front chamber and the rear chamber, a bypass for transferring the liquid component between the front chamber and the rear chamber, and a rear piston. The cartridge is slidably arranged within a cylindrical sleeve substantially the same length as the cartridge. A stopper is located in the vicinity of the front opening of the cartridge. The stopper is directed rearwardly coaxially with the cartridge, wherein as the sleeve is displaced rearwardly after the freeze-drying of the drug, the stopper enters the front opening of the cartridge to sealingly close the cartridge. An actuator for actuating the rear piston may be attached in the vicinity of the rear end of the cartridge.|
|Inventor(s):|| Hjertman; Birger (Vallingby, SE), Levander; Gustav (Bromma, SE), Ljungquist; Olle (Taby, SE) |
|Assignee:|| Pharmacia Aktiebolag (SE) |
Patent Claim Types:|
see list of patent claims
|Device; Delivery; Use; Process; Formulation; |
No matches for this query
Foreign Priority and PCT Information for Patent: 5,435,076
|Foriegn Application Priority Data|
||Foreign Patent Number
||Foreign Patent Date
|Sweden||9201247||Apr 21, 1992|
|PCT Filed||April 16, 1993||PCT Application Number:||PCT/SE93/00336|
|PCT Publication Date:||October 28, 1993||PCT Publication Number:||
International Patent Family for Patent: 5,435,076
The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws,
it is advisable to have patent counsel verify freedom to operate.
Serving leading biopharmaceutical companies globally:
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.